Vivanza Biosciences Ltd. benchmarking: Perfomance to industry peers

Financial

	Vivanza Biosciences	Tiaan Consumer	Devine Impex
Operational Metrics
Financials
5 yr Average ROE	4.27 %	-5.63 %	2.74 %
5yr average Equity Multiplier	4.19	72.93	1.7
5yr Average Asset Turnover Ratio	0.9	0.07	0.32
5yr Avg Net Profit Margin	0.04 %	-219.38 %	2.72 %
Price to Book	1.95	1.3	0.66
P/E	0.0	0.0	296.81
5yr Avg Cash Conversion Cycle	296.4 Days	0.0	1193.02 Days
Inventory Days	53.72 Days	954.72 Days	803.14 Days
Days Receivable	481.83 Days	0.0	327.33 Days
Days Payable	199.57 Days	971.34 Days	17.92 Days
5yr Average Interest Coverage Ratio	1.5	406.51	80.68
5yr Avg ROCE	12.63 %	-4.4 %	3.94 %
5yr Avg Operating Profit Margin	0.66 %	-172.84 %	3.47 %
5 yr average Debt to Equity	1.39	71.82	0.6
5yr CAGR Net Profit	n/a	-49.79 %	-34.73 %
5yr Average Return on Assets	0.88 %	-4.35 %	0.94 %
Shareholdings
Promoter Holding	20.02 %	0.02 %	34.54 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-27.78 %	-8.59 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0